Most importantly, these authors showed that by using 25mg/kg LQZ-7F via intraperitoneal injection once every 3 days for a total of eight treatments, LQZ-7F significantly inhibits PC3-established xenograft tumor growth by inhibiting survivin without inducing mouse body weight loss [33]. The gene discussed is BIRC5; the disease is neoplasm.